WorldHeart starts VAD trial
This article was originally published in The Gray Sheet
Executive Summary
Human implantation of the firm's rotary ventricular assist device (VAD) occurred March 8 in Greece, kicking off a feasibility trial for the device. WorldHeart will seek a bridge-to-transplant indication initially, but eventually aspires to sell the device as a destination therapy. The firm received approval from the Greek Ministry of Health to begin the trial in February (1"The Gray Sheet" Feb. 20, 2006, In Brief)...